Viewing Study NCT06492759


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-02-24 @ 8:13 PM
Study NCT ID: NCT06492759
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-16
First Post: 2024-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
Sponsor: Emory University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: STUDY00005578
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View